Rp-cAMPS

CAT: 0804-HY-100530ASize: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-100530ASize:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Rp-cAMPS, a cAMP analog, is a potent, competitive cAMP-induced activation of cAMP-dependent PKA I and II (Kis of 12.5 μM and 4.5 μM, respectively) antagonist. Rp-cAMPS is resistant to hydrolysis by phosphodiesterases[1][2][3][4][5][6].
CAS Number
[73208-40-9]
UNSPSC
12352005
Target
PKA
Type
Reference compound
Related Pathways
Stem Cell/Wnt; TGF-beta/Smad
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/rp-camps.html
Solubility
10 mM in DMSO
Smiles
O[C@H]1[C@@H](O[C@@]2([H])[C@@]1([H])O[P@@](OC2)(S)=O)N3C4=C(C(N)=NC=N4)N=C3
Molecular Formula
C10H12N5O5PS
Molecular Weight
345.27
References & Citations
[1] Rothermel JD, et al. A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3',5'- (cyclic) phosphorothioate with purified cyclic AMP-dependent protein kinase. Biochem J. 1988 May 1;251 (3) :757-62.|[2]Fu Y, et al. PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior. Mol Pain. 2008 Jul 16;4:26.|[3]Kuriyama S, et al. Isoproterenol inhibits rod outer segment phagocytosis by both cAMP-dependent and independent pathways. Invest Ophthalmol Vis Sci. 1995 Mar;36 (3) :730-6.|[4]Dostmann WR, et al. Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates. J Biol Chem. 1990 Jun 25;265 (18) :10484-91.|[5]Van Haastert PJ, et al. Competitive cAMP antagonists for cAMP-receptor proteins. J Biol Chem. 1984 Aug 25;259 (16) :10020-4.|[6]R J de Wit, et al. Inhibitory action of certain cyclophosphate derivatives of cAMP on cAMP-dependent protein kinases. Eur J Biochem. 1984 Jul 16;142 (2) :255-60.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Citation 01
Theranostics. 2021 Mar 24;11 (12) :5650-5674.|Cell Commun Signal. 2024 Jun 3;22 (1) :307.|Nat Commun. 2025 Jul 1;16 (1) :5425.|Research Square Preprint. 2024 Apr 9.

Related Products

CatalogName
HY-137640BRp-8-Br-cAMPS
HY-120994ARp-8-CPT-cAMPS
HY-137640C-01Rp-8-Br-cAMPS (sodium)
HY-120994Rp-8-CPT-cAMPS (sodium)
HY-100530BSp-cAMPS
HY-137624Sp-cAMPS-AM
HY-101939RP-001
HY-110005Sp-cAMPS (triethylamine)
HY-116260RP-69758
HY-P11107-01RP-832c

Alternative Products

CatalogName
sc-24010Rp-cAMPS
BUP21954Rp-cAMPS sodium
MBS3841335-01cAMPS-Rp, triethylammonium salt
MBS5797766Rp-cAMPS sodium salt
BLG-A120-05Rp-2′-AHC-cAMPS
BLG-P029Rp-6-Phe-cAMPS
BLG-A085-25Rp-8-AHA-cAMPS
BLG-B001-05Rp-8-Br-cAMPS
BLG-C003-25Rp-8-Cl-cAMPS
BLG-A002S-25Rp-cAMPS . sodium salt

Popular Products